Search

everythinglearnresearchcommunity

for

Search:↓

Hair cortisol is a reliable marker of long-term cortisol levels and is linked to daytime saliva cortisol but not morning levels.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Hair cortisol levels peak in the third trimester and decline postpartum.

Girls had higher stress hormone levels during school due to social and emotional issues, while boys had higher overall hormone levels with slight changes when school started.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Hair cortisol levels in primates are useful for stress assessment but vary by age, sex, species, and hair collection methods.

Hair cortisol levels can reflect salivary cortisol levels in humans.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Hair loss in postmenopausal woman caused by ovarian issue.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Skin issues are common and important for diagnosing PCOS.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

High androgen levels in young women with PCOS are linked to higher blood pressure.